Literature DB >> 24681044

ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.

Jeffrey L Anderson, Paul A Heidenreich, Paul G Barnett, Mark A Creager, Gregg C Fonarow, Raymond J Gibbons, Jonathan L Halperin, Mark A Hlatky, Alice K Jacobs, Daniel B Mark, Frederick A Masoudi, Eric D Peterson, Leslee J Shaw.   

Abstract

Keywords:  ACC/AHA guidelines; ACC/AHA performance measures; cost; quality indicators; quality measurement

Mesh：

Year:  2014        PMID： 24681044     DOI： 10.1016/j.jacc.2014.03.016

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  99 in total

Review 1.  Cholesterol Management in the Era of PCSK9 Inhibitors.

Authors:  Anna Svatikova; Stephen L Kopecky
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Preliminary report on the cost effectiveness of ventricular assist devices.

Authors:  Tomoyuki Takura; Shunei Kyo; Minoru Ono; Ryuji Tominaga; Shigeru Miyagawa; Yoshihisa Tanoue; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2015-08-05       Impact factor: 1.731

Review 3.  Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?

Authors:  Stefan Weisshaar; Markus Zeitlinger
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

4.  Cost-Effectiveness of a US National Sugar-Sweetened Beverage Tax With a Multistakeholder Approach: Who Pays and Who Benefits.

Authors:  Parke Wilde; Yue Huang; Stephen Sy; Shafika Abrahams-Gessel; Thiago Veiga Jardim; Robert Paarlberg; Dariush Mozaffarian; Renata Micha; Thomas Gaziano
Journal:  Am J Public Health       Date:  2018-12-20       Impact factor: 9.308

5.  American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Authors:  Lowell E Schnipper; Nancy E Davidson; Dana S Wollins; Courtney Tyne; Douglas W Blayney; Diane Blum; Adam P Dicker; Patricia A Ganz; J Russell Hoverman; Robert Langdon; Gary H Lyman; Neal J Meropol; Therese Mulvey; Lee Newcomer; Jeffrey Peppercorn; Blase Polite; Derek Raghavan; Gregory Rossi; Leonard Saltz; Deborah Schrag; Thomas J Smith; Peter P Yu; Clifford A Hudis; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2015-06-22       Impact factor: 44.544

6.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

7.  Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation.

Authors:  Bart S Ferket; Vinod H Thourani; Pierre Voisine; Samuel F Hohmann; Helena L Chang; Peter K Smith; Robert E Michler; Gorav Ailawadi; Louis P Perrault; Marissa A Miller; Karen O'Sullivan; Stephanie L Mick; Emilia Bagiella; Michael A Acker; Ellen Moquete; Judy W Hung; Jessica R Overbey; Anuradha Lala; Margaret Iraola; James S Gammie; Annetine C Gelijns; Patrick T O'Gara; Alan J Moskowitz
Journal:  J Thorac Cardiovasc Surg       Date:  2019-07-02       Impact factor: 5.209

8.  Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study.

Authors:  Daniel A Steinhaus; Peter J Zimetbaum; Rod S Passman; Peter Leong-Sit; Matthew R Reynolds
Journal:  J Cardiovasc Electrophysiol       Date:  2016-10-04

9.  Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States.

Authors:  Eric L Ross; Jessica E Becker; Jenny J Linnoila; Djøra I Soeteman
Journal:  J Clin Psychiatry       Date:  2020-11-17       Impact factor: 4.384

Review 10.  Implantable devices to monitor patients with heart failure.

Authors:  Nikolaos Karamichalakis; John Parissis; George Bakosis; Vasiliki Bistola; Ignatios Ikonomidis; Antonios Sideris; Gerasimos Filippatos
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.